Skip to main content
. 2014 Jul 15;9(7):e102556. doi: 10.1371/journal.pone.0102556

Table 6. Distribution of diplotype, ATTGCT/ATTGCT (PIP4K2A) and its association analysis with drug response in schizophrenia patients (n = 423), atypical monotherapy (n = 355) and risperidone group (n = 260).

Groups SNPs Number (frequency) OR (95%CI) P-value
CR IR
Schizophrenia patients
Low severity rs746203|rs10828317|rs7094131|rs2296624|rs11013052|rs1409396 33 (0.67) 16 (0.32) 1.51 (0.69–3.22) 0.252
High severity rs746203|rs10828317|rs7094131|rs2296624|rs11013052|rs1409396 9 (0.14) 55 (0.85) 3.37 (1.51–8.28) 0.001a
Atypical monotherapy group
Low severity rs746203|rs10828317|rs7094131|rs2296624|rs11013052|rs1409396 28 (0.68) 13 (0.31) 1.34 (0.57–3.04) 0.458
High severity rs746203|rs10828317|rs7094131|rs2296624|rs11013052|rs1409396 7 (0.14) 43 (0.86) 3.6 (1.45–10.15) 0.002a
Risperidone group
Low severity rs746203|rs10828317|rs7094131|rs2296624|rs11013052|rs1409396 16 (0.59) 11 (0.40) 1.83 (0.66–4.90) 0.18
High severity rs746203|rs10828317|rs7094131|rs2296624|rs11013052|rs1409396 4 (0.10) 35 (0.89) 5.09 (1.62–21.01) 0.002a

Footnote: Haplotype withstand Bonferonni correction was included for diplotype analysis. Diplotype with minimum frequency less than 0.10 were ignored.

a

P-values less than threshold value of α which is equal to 0.05/6(n) = 0.008, where n is number of test for diplotype association analysis.

CR, Complete responders; IR, Incomplete responders; OR, Odds ratio; CI, Confidence interval.